Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 10Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell 5Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, Follicular 3Burkitt Lymphoma 3Myelodysplastic Syndromes 2Lymphoma, Mantle-Cell 2Sarcoma, Kaposi 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multi-centric Castleman's Disease 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Castleman Disease 1Acquired Immunodeficiency Syndrome 1

Interventions

Zidovudine 2Vincristine 2Valganciclovir 2Rituximab 2Prednisone 2Etoposide 2Doxorubicin 2Cyclophosphamide 2tocilizumab 1tanespimycin 1liposomal doxorubicin 1ibrutinib 1deltacortene 1Sirolimus 1Polymerase Chain Reaction 1Methotrexate 1Interferon-alpha 1Hyaluronoglucosaminidase 1Histological Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1CT-P10 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multi-centric Castleman's Disease × tocilizumab × Lymphoid × Clear all
NCT01441063 2020-10-27

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
8 enrolled 18 charts
LymphoidSarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Castleman Disease, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡